New ultrasound method may speed up liver cancer treatment decisions
NCT ID NCT07145801
First seen Oct 31, 2025 · Last updated Jun 17, 2026 · Updated 31 times
Summary
This study tests whether contrast-enhanced ultrasound (CEUS) can more accurately show if liver cancer (HCC) has been killed by a treatment called radioembolization (TARE). Standard CT or MRI scans often take months to give a clear answer, which can delay needed retreatment. Researchers will enroll 30 patients and compare CEUS results to standard scans at 1-2 and 4-6 months after TARE. The goal is to see if CEUS can provide faster, clearer results to guide next steps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.